Alzheimer's disease: 19th CTAD announcement
Mark the date and location on your calendar.
|
Read next
Recent advances in Alzheimer’s disease research
Alzheimer’s disease is a complex neurodegenerative disorder that develops over several decades before clear clinical signs become visible. For many years, both basic and clinical research focused mainly on neuronal integrity and on the amyloid-beta hypothesis, which proposed that the disease could be treated by reducing plaque accumulation in
An update on recent deals
In our first two reports of the year, we noted that most biotechnology CEOs were concerned that, after a difficult and "morose" 2025, their companies faced an uncertain future. At the same time, investors had already identified a shift toward higher-value transactions and expected M&A activity
The top 10 pharma R&D budgets of 2025
According to Fierce Biotech Week, published on March 30, 2026
Top 10 pharma R&D budgets in 2025
Preamble.
The top ten pharmaceutical companies with the largest research and development (R&D) budgets in 2025 remain unchanged from the previous year, with only minor shifts in their rankings.
Comments ()